2026 NPPES data Interventional Cardiology Physician NPI 1174918536 M.D.
Verify on CMS →

KASSRA POOSTI, M.D.

Interventional Cardiology Physician in WEST HILLS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 400 beneficiaries · Interventional Cardiology Physician avg: 3K
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$25.09
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KASSRA POOSTI, M.D. filed 1,465 Medicare Part D claims in 2023 as a Interventional Cardiology Physician in WEST HILLS, California, prescribing 77% generic.

1K
Part D claims, 2023
77%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KASSRA POOSTI, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,465 Top 20% higher than 80% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). This entry sits in this band. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

KASSRA POOSTI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KASSRA POOSTI, M.D.?

Quality data not reported

NPI registry status

Active

Issued 04/02/2015

NPI 1174918536

Primary specialty

Interventional Cardiology Physician

Niche

3,382 US NPIs in this specialty

Medicare Part D claims

1,465 51% vs specialty avg

2023 prescription claims

Specialty avg: 2,984

Specialty distribution in California

How Interventional Cardiology Physician compares to other specialties among California providers

California providers

Interventional Cardiology Physician share within California

1. Interventional Cardiology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Interventional Cardiology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Interventional Cardiology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Interventional Cardiology Physician ABMS/AOA estimate

Est. board-certified rate (Interventional Cardiology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Interventional Cardiology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KASSRA POOSTI, M.D. is a Interventional Cardiology Physician provider practicing in WEST HILLS, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1174918536. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

KASSRA POOSTI, M.D. appears in the CMS NPPES registry as a Interventional Cardiology Physician provider holding M.D. credentials at 7301 MEDICAL CENTER DR STE 201, WEST HILLS, CA, 91307, with a listed phone of (818) 702-8800. NPI 1174918536 was issued on 04/02/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what POOSTI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,465 prescription claims written by this provider, covering 400 Medicare beneficiaries and totaling roughly $163K in drug spend, split 23% brand-name and 77% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Interventional Cardiology Physician is a narrow specialty nationwide, with 3,382 enrolled providers across 53 states and an average of 2,984 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7301 MEDICAL CENTER DR STE 201
WEST HILLS, CA 91307

Provider Details

NPI 1174918536
Specialty Interventional Cardiology Physician
Credentials M.D.
Gender Male
NPI Issued 04/02/2015

Hospital and facility affiliations

Facilities where KASSRA POOSTI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

INTERVENTIONAL CARDIOLOGY MEDICAL GROUP, INC
WEST HILLS, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KASSRA POOSTI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$25

Largest payer

Boston Scientific Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to KASSRA POOSTI, M.D.. To verify KASSRA POOSTI, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

KASSRA POOSTI, M.D. — brand share 23.0%
Specialty average (est.)

23% brand-name claims vs 77% generic, on 1,465 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,465
Total Claims
$163K
Total Drug Cost
400
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,345
Total Day Supply
130,245
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$143K
Generic Drug Cost
$20K

Patient Demographics

Average Patient Age
76.4 years
Avg HCC Risk Score
1.46
Gender Split
44% female / 56% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Pradaxa
Dabigatran Etexilate Mesylate
207
Metoprolol Tartrate
142
Atorvastatin Calcium
129
Clopidogrel
Clopidogrel Bisulfate
89
Amlodipine Besylate
84
Carvedilol
73
Bisoprolol Fumarate
71
Furosemide
68
Losartan Potassium
67
Lisinopril
62

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Interventional Cardiology Physician Overview

How KASSRA POOSTI, M.D. fits within the Interventional Cardiology Physician landscape nationally.

3,382
Interventional Cardiology Physician Providers in US
53
States with Interventional Cardiology Physician
2,984
Avg Claims per Provider

KASSRA POOSTI, M.D.'s 1,465 claims are below the specialty average of 2,984.

Nearby Interventional Cardiology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as POOSTI.

Compare Interventional Cardiology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KASSRA POOSTI, M.D.'s specialty?
KASSRA POOSTI, M.D. specializes in Interventional Cardiology Physician and practices in WEST HILLS, California. Credentials: M.D..
How much does KASSRA POOSTI, M.D. prescribe under Medicare Part D?
In 2023, KASSRA POOSTI, M.D. wrote 1,465 Medicare Part D claims totaling $163K in drug costs for 400 beneficiaries.
Where is KASSRA POOSTI, M.D. located?
KASSRA POOSTI, M.D. is located at 7301 MEDICAL CENTER DR STE 201, WEST HILLS, CA, 91307. Phone: (818) 702-8800.
What is KASSRA POOSTI, M.D.'s NPI number?
KASSRA POOSTI, M.D.'s National Provider Identifier (NPI) is 1174918536, issued on 04/02/2015.
Does KASSRA POOSTI, M.D. prescribe more brand-name or generic drugs?
KASSRA POOSTI, M.D.'s prescribing is 23% brand-name and 77% generic drugs by claim count, with $143K in brand drug costs.
How many Interventional Cardiology Physician providers are there in the US?
There are 3,382 Interventional Cardiology Physician providers across 53 states in the US. The average Interventional Cardiology Physician provider writes 2,984 Medicare Part D claims per year.
What drugs does KASSRA POOSTI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, KASSRA POOSTI, M.D.'s most frequently prescribed drugs include Pradaxa, Metoprolol Tartrate, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KASSRA POOSTI, M.D. accept Medicare?
KASSRA POOSTI, M.D. appears in CMS Medicare data with 1,465 Part D claims and 400 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KASSRA POOSTI, M.D.'s credentials?
KASSRA POOSTI, M.D.'s NPI is 1174918536 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology